{"id":"https://openalex.org/W2622197960","doi":"https://doi.org/10.1080/13543776.2017.1339688","title":"MEK inhibitors in oncology: a patent review (2015-Present)","display_name":"MEK inhibitors in oncology: a patent review (2015-Present)","alternate_titles":[],"publication_year":2017,"publication_date":"2017-06-19","ids":{"openalex":"https://openalex.org/W2622197960","doi":"https://doi.org/10.1080/13543776.2017.1339688","mag":"2622197960","pmid":"https://pubmed.ncbi.nlm.nih.gov/28594589"},"language":"en","primary_location":{"id":"doi:10.1080/13543776.2017.1339688","doi":"https://doi.org/10.1080/13543776.2017.1339688","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13543776.2017.1339688","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2622197960"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051968939","display_name":"Debarshi Kar Mahapatra","orcid":"https://orcid.org/0000-0002-3986-0337","observed_orcids":["https://orcid.org/0000-0002-3986-0337"]},"institutions":[{"id":"https://openalex.org/I133978751","display_name":"Rashtrasant Tukadoji Maharaj Nagpur University","ror":"https://ror.org/04esgv207","country_code":"IN","type":"education","lineage":["https://openalex.org/I133978751"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Debarshi Kar Mahapatra","raw_affiliation_strings":["Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India","institution_ids":["https://openalex.org/I133978751"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086658025","display_name":"Vivek Asati","orcid":"https://orcid.org/0000-0003-4990-7757","observed_orcids":["https://orcid.org/0000-0003-4990-7757"]},"institutions":[{"id":"https://openalex.org/I26285277","display_name":"Guru Ghasidas Vishwavidyalaya","ror":"https://ror.org/05bvxq496","country_code":"IN","type":"education","lineage":["https://openalex.org/I26285277"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vivek Asati","raw_affiliation_strings":["Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, India","institution_ids":["https://openalex.org/I26285277"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037984928","display_name":"Sanjay Kumar Bharti","orcid":"https://orcid.org/0000-0003-3874-1149","observed_orcids":["https://orcid.org/0000-0003-3874-1149"]},"institutions":[{"id":"https://openalex.org/I26285277","display_name":"Guru Ghasidas Vishwavidyalaya","ror":"https://ror.org/05bvxq496","country_code":"IN","type":"education","lineage":["https://openalex.org/I26285277"]}],"countries":["IN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Sanjay Kumar Bharti","raw_affiliation_strings":["Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, India","institution_ids":["https://openalex.org/I26285277"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5037984928"],"corresponding_institution_ids":["https://openalex.org/I26285277"],"apc_list":null,"apc_paid":null,"fwci":0.4691,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.41793381,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"27","issue":"8","first_page":"887","last_page":"906"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":1.0},{"id":"https://openalex.org/keywords/ras-mapk-pathway","display_name":"RAS/MAPK pathway","score":0.8949999809265137},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.9750000238418579},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9520000219345093},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.949999988079071},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/multikinase-inhibitor","display_name":"multikinase inhibitor","score":0.7120000123977661},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7269999980926514},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.8930000066757202},{"id":"https://openalex.org/keywords/colorectal-adenocarcinoma","display_name":"colorectal adenocarcinoma","score":0.9340000152587891},{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.6050000190734863},{"id":"https://openalex.org/keywords/pharmaceutical-patents","display_name":"pharmaceutical patents","score":0.3059999942779541}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.799475371837616},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6924135088920593},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6657416820526123},{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.6234691143035889},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.6121343970298767},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5807271003723145},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5761440396308899},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5461295247077942},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.48999062180519104},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.47088557481765747},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.46735456585884094},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46051090955734253},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.425135999917984},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3064175844192505},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24745053052902222},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.23707687854766846},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23401838541030884},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020929","descriptor_name":"Mitogen-Activated Protein Kinase Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020929","descriptor_name":"Mitogen-Activated Protein Kinase Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020929","descriptor_name":"Mitogen-Activated Protein Kinase Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/13543776.2017.1339688","doi":"https://doi.org/10.1080/13543776.2017.1339688","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13543776.2017.1339688","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},{"id":"pmid:28594589","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28594589","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on therapeutic patents","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320767","display_name":"University Grants Commission","ror":"https://ror.org/04p800546"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W270321414","https://openalex.org/W584714177","https://openalex.org/W1502520548","https://openalex.org/W1509279077","https://openalex.org/W1581756415","https://openalex.org/W1601862985","https://openalex.org/W1790589966","https://openalex.org/W1843780900","https://openalex.org/W1965097080","https://openalex.org/W1971977518","https://openalex.org/W1974564127","https://openalex.org/W1992843538","https://openalex.org/W1998203489","https://openalex.org/W2000149240","https://openalex.org/W2011826559","https://openalex.org/W2017461976","https://openalex.org/W2037758170","https://openalex.org/W2047198790","https://openalex.org/W2047401805","https://openalex.org/W2047942701","https://openalex.org/W2049171090","https://openalex.org/W2050206485","https://openalex.org/W2051165598","https://openalex.org/W2063355387","https://openalex.org/W2072687123","https://openalex.org/W2074089133","https://openalex.org/W2079478551","https://openalex.org/W2080804401","https://openalex.org/W2088422652","https://openalex.org/W2101477408","https://openalex.org/W2114502358","https://openalex.org/W2116386978","https://openalex.org/W2116606378","https://openalex.org/W2122861469","https://openalex.org/W2124482167","https://openalex.org/W2129429534","https://openalex.org/W2135184154","https://openalex.org/W2136604673","https://openalex.org/W2138498601","https://openalex.org/W2156509877","https://openalex.org/W2233607184","https://openalex.org/W2333950962","https://openalex.org/W2460264586","https://openalex.org/W2492626689","https://openalex.org/W2497772508","https://openalex.org/W2569843435","https://openalex.org/W2580797514","https://openalex.org/W2583156538","https://openalex.org/W2611720033","https://openalex.org/W2756387813","https://openalex.org/W2782112594","https://openalex.org/W2813227355","https://openalex.org/W2853691869","https://openalex.org/W2868783975","https://openalex.org/W3098045732"],"related_works":["https://openalex.org/W4402542455","https://openalex.org/W2080804401","https://openalex.org/W2039924299","https://openalex.org/W2617846385","https://openalex.org/W2040693125","https://openalex.org/W2791537298","https://openalex.org/W2089832100","https://openalex.org/W2184117613","https://openalex.org/W2923849202","https://openalex.org/W2751927488"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1,55,118,136,160,175],"RAS/RAF/MEK/ERK":[2],"and":[3,21,95,157,172],"PI3K/AKT/mTOR":[4],"signaling":[5],"pathways":[6,20],"have":[7,65,109],"been":[8,28,99],"identified":[9],"as":[10,30,133],"promising":[11,67,122,148],"therapeutic":[12,185],"targets":[13],"for":[14,187],"cancer":[15,190],"therapy.":[16],"Over-activation":[17],"of":[18,32,36,46,79,165,192],"these":[19],"their":[22,89],"components":[23],"including":[24],"gene":[25,63,180],"mutations":[26],"has":[27,98],"considered":[29],"one":[31],"the":[33,80,163,188],"major":[34],"causes":[35],"melanoma.":[37,73,117,159],"Mitogen-activated":[38],"protein":[39,105],"kinase":[40,45,93,106],"(MEK)":[41,107],"is":[42],"a":[43,184],"downstream":[44],"RAS":[47],"pathway":[48],"found":[49],"in":[50,58,69,113,116,124,139,150,169],"two":[51],"different":[52],"forms":[53],"MEK1/2.":[54],"MEK":[56,87,119],"inhibitors":[57,64,94,108,120,138,146,181],"combination":[59,140,161,176],"with":[60,71,91,126,141,194],"other":[61,92],"kinase/mutant":[62,179],"shown":[66],"results":[68,123,149],"patients":[70,125,193],"metastatic":[72,127],"Areas":[74],"covered:":[75],"A":[76],"comprehensive":[77],"review":[78],"patent":[81],"literature":[82],"(2015":[83],"-":[84],"Present)":[85],"on":[86],"inhibitors,":[88],"combinations":[90],"structural":[96],"insights":[97],"highlighted.":[100],"Expert":[101],"opinion:":[102],"Recently":[103],"mitogen-activated":[104],"attracted":[110],"considerable":[111],"interest":[112],"oncology":[114],"especially":[115],"showed":[121,147],"melanoma":[128],"harboring":[129],"mutant":[130],"genes":[131],"such":[132],"BRAF,":[134,142],"KRAS.":[135],"MEK1/2":[137],"KRAS":[143],"and/or":[144,177],"PI3K":[145],"mutated":[151],"colorectal,":[152],"pancreatic":[153],"adenocarcinoma,":[154],"solid":[155],"tumor,":[156],"relapsed/refractory":[158],"delays":[162],"onset":[164],"acquired":[166],"resistance,":[167],"resulting":[168],"increased":[170],"progression-free":[171],"overall":[173],"survival.":[174],"multi-targeted":[178],"may":[182],"be":[183],"option":[186],"personalized":[189],"treatment":[191],"relapsed":[195],"or":[196],"refractory":[197],"multiple":[198],"myeloma.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2622197960","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-06-15T00:00:00"}
